Chasmanine is primarily studied for its potential neuropharmacological effects, particularly in the context of central nervous system modulation. It has shown activity as a modulator of sodium channels, which may contribute to analgesic and anticonvulsant properties in preclinical models. Due to its structural complexity and bioactivity, it serves as a lead compound in the development of novel agents targeting neurological disorders. Additionally, chasmanine has been investigated for anti-inflammatory and cardioprotective effects, though research remains largely experimental. Its use is currently limited to laboratory and research settings, with no approved clinical applications to date.